Cancer cells undergoing complete EMT acquire mesenchymal markers such as vimentin (VIM), and lose epithelial markers such as E-cadherin (ECAD) (35), whereas cancer cells undergoing partial EMT (p-EMT) co-express epithelial and mesenchymal markers (38, 56), but may re-localize epithelial proteins from cell-cell junctions to cytoplasm to reduce cell-cell adhesion and increase motility (36, 37). The gene discussed is CDH1; the disease is cancer.